Clinical Trials Browser

INDUSTRY × proxalutamide × Genitourinary × Clear all

NCT03899467 2024-02-12

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Phase 2 Completed

61 enrolled 12 charts

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Phase NA Completed

268 enrolled 8 charts

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

NCT02826772 2020-03-17

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Phase 1 Completed

Metastatic Castrate Resistant Prostate Cancer (mCRPC)